These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 32723434)

  • 21. Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Tormene D; Hoxha A; Fedrigo M; Simioni P
    Clin Chim Acta; 2015 Jun; 446():201-5. PubMed ID: 25935129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome.
    Pericleous C; Ferreira I; Borghi O; Pregnolato F; McDonnell T; Garza-Garcia A; Driscoll P; Pierangeli S; Isenberg D; Ioannou Y; Giles I; Meroni PL; Rahman A
    PLoS One; 2016; 11(6):e0156407. PubMed ID: 27253369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of anti-domain 1 β2-glycoprotein I antibodies in antiphospholipid syndrome.
    Iwaniec T; Kaczor MP; Celińska-Löwenhoff M; Polański S; Musiał J
    Thromb Res; 2017 May; 153():90-94. PubMed ID: 28363116
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical performance of a chemiluminescent immunoassay in detecting anti-cardiolipin and anti-β2 glycoprotein I antibodies. A comparison with a homemade ELISA method.
    Meneghel L; Ruffatti A; Gavasso S; Tonello M; Mattia E; Spiezia L; Campello E; Hoxha A; Fedrigo M; Punzi L; Simioni P
    Clin Chem Lab Med; 2015 Jun; 53(7):1083-9. PubMed ID: 25720075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in patients with primary antiphospholipid syndrome.
    Signorelli F; Balbi GGM; Aikawa NE; Silva CA; Kupa LVK; Medeiros-Ribeiro AC; Yuki EF; Pasoto SG; Saad CG; Borba EF; Seguro LPC; Pedrosa T; Oliveira VAA; Costa ALCS; Ribeiro CT; Santos REB; Andrade DCO; Bonfá E
    Lupus; 2022 Jul; 31(8):974-984. PubMed ID: 35593174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
    Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
    Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploring the impact of acute viral exposure on clinical characteristics and antibody profiles in antiphospholipid syndrome: a study in CAPSTONE.
    Wang C; Jiang H; Chen S; Zhao Y; Li J; Huang C; Zhou Y; Wang Q; Tian X; Li M; Zeng X; Zhao Y; Wu C; Zhao J
    Clin Exp Med; 2024 Jun; 24(1):130. PubMed ID: 38888664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
    Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
    Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does the anti-beta2-glycoprotein I antibody provide additional information in patients with thrombosis?
    Lee EY; Lee CK; Lee TH; Chung SM; Kim SH; Cho YS; Yoo B; Moon HB
    Thromb Res; 2003; 111(1-2):29-32. PubMed ID: 14644075
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
    Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
    Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IgM, but not IgA rheumatoid factor interferes with anti-cardiolipin and antiβ2 glycoprotein I measurements: a quantitative analysis.
    Lakos G; Teodorescu M
    Lupus; 2011 May; 20(6):614-9. PubMed ID: 21436214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel enzyme immunoassay system for simultaneous detection of six subclasses of antiphospholipid antibodies for differential diagnosis of antiphospholipid syndrome.
    Nojima J; Motoki Y; Hara K; Sakata T; Ichihara K
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):316-322. PubMed ID: 27676644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
    Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
    Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients.
    Elbagir S; Elshafie AI; Elagib EM; Mohammed NA; Aledrissy MI; Manivel VA; Pertsinidou E; Nur MA; Gunnarsson I; Svenungsson E; Rönnelid J
    Lupus; 2020 Oct; 29(11):1412-1422. PubMed ID: 32741301
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analytical and clinical comparison of different immunoassay systems for the detection of antiphospholipid antibodies.
    Montaruli B; De Luna E; Erroi L; Marchese C; Mengozzi G; Napoli P; Nicolo' C; Romito A; Bertero MT; Sivera P; Migliardi M
    Int J Lab Hematol; 2016 Apr; 38(2):172-82. PubMed ID: 26847159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Relevance of Isolated Lupus Anticoagulant Positivity in Patients with Thrombotic Antiphospholipid Syndrome.
    Yin D; de Groot PG; Ninivaggi M; Devreese KMJ; de Laat B
    Thromb Haemost; 2021 Sep; 121(9):1220-1227. PubMed ID: 33385181
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome.
    Nuri E; Taraborelli M; Andreoli L; Tonello M; Gerosa M; Calligaro A; Argolini LM; Kumar R; Pengo V; Meroni PL; Ruffatti A; Tincani A
    Immunol Res; 2017 Feb; 65(1):17-24. PubMed ID: 27406736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgA is the predominant isotype of anti-β2 glycoprotein I in patients with COVID-19.
    Melayah S; Omrani N; Alouini H; Ghozzi M; Mrad S; Boussarsar M; Chaouch H; Hachfi W; Letaief A; Mankaï A; Ghedira I
    Lab Med; 2024 May; 55(3):373-379. PubMed ID: 38124622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High prevalence of antiphospholipid antibodies in leprosy: evaluation of antigen reactivity.
    de Larrañaga GF; Forastiero RR; Martinuzzo ME; Carreras LO; Tsariktsian G; Sturno MM; Alonso BS
    Lupus; 2000; 9(8):594-600. PubMed ID: 11035434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pulmonary events in antiphospholipid syndrome: influence of antiphospholipid antibody type and levels.
    Stojanovich L; Kontic M; Djokovic A; Ilijevski N; Stanisavljevic N; Marisavljevic D
    Scand J Rheumatol; 2012 May; 41(3):223-6. PubMed ID: 22324785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.